Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone for Psychiatric Symptoms in Alcohol Dependence
NCT00197951Phase 3Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol use disorder (AUD), major depressive disorder (MDD), anxiety disorder and 1 more comparing Ziprasidone with Placebo (2 arms). Primary endpoint: Symptom Checklist-90-Revised Score. Started Oct 2004; status: completed.
02
Drugs
ziprasidone
03
Conditions
alcohol use disorder (AUD)major depressive disorder (MDD)anxiety disorderintermittent explosive disorder (IED)
Beyond the preview
Go deeper on NCT00197951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197951.